Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09
2. Recent advances in nanocarriers for clinical platinum(II) anticancer drugs;Coordination Chemistry Reviews;2024-04
3. Renal Toxicology/Nephrotoxicity of Metals and Nanometallic Particles: Arsenic, Bismuth, Cadmium, Chromium, Indium, Lead, Platinum, Tungsten, Uranium, and Metallic Mixtures;Reference Module in Biomedical Sciences;2024
4. Self-assembled amphiphilic bipyridine and bisquinoline cisplatin analogues: synthesis and anticancer properties;Medicinal Chemistry Research;2023-12-23
5. Proteomics reveals that cell density could affect the efficacy of drug treatment;Biochemistry and Biophysics Reports;2023-03